1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10830)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22056)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC)
    Meeting Abstract

    Coleman, R. L.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Immune-active microenvironment in SCCOHT: Rationale for therapy with immune checkpoint blockade
    Meeting Abstract

    Van Oudenhove, E.; Jelinic, P.; Ricca, J.; Olvera, N.; Merghoub, T.; Levine, D. A.; Dmitriy, Z.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Lineage plasticity in antiandrogen resistance
    Meeting Abstract

    Abida, W.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Family history of prostate cancer and the incidence of ERG- and PTEN-defined prostate cancer
    Meeting Abstract

    Hashim, D.; Gonzalez-Feliciano, A. G.; Ahearn, T. U.; Pettersson, A.; Barber, L.; Pernar, C. H.; Ebot, E. M.; Finn, S.; Giovannucci, E. L.; Lis, R. T.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Aberrant activation of a gastrointestinal transcriptional circuit in prostate cancer mediates castration resistance
    Meeting Abstract

    Shukla, S.; Cyrta, J.; Murphy, D.; Walczak, E.; Ran, L. L.; Agrawal, P.; Xie, Y.; Chen, Y.; Wang, S.; Zhan, Y.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS)
    Meeting Abstract

    Tabernero, J.; Shitara, K.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety results from IMblaze370, a randomised phase III study comparing atezolizumab + cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer
    Meeting Abstract

    Bendell, J.; Ciardiello, F.; Tabernero, J.; Tebbutt, N.; Eng, C.; Di Bartolomeo, M.; Falcone, A.; Fakih, M.; Kozloff, M.; Segal, N.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Two-year efficacy and safety update from JAVELIN Merkel 200 Part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Meeting Abstract

    Sandhu, S.; Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; more...
    Asia-Pacific Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Activity of larotrectinib in patients with TRK fusion GI malignancies
    Meeting Abstract

    Nathenson, M.; Demetri, G.; Lassen, U.; Hong, D.; Boni, V.; Deeken, J.; Dowlati, A.; Cox, M.; Ku, N.; Cruickshank, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Assessment of tumor response, AFP response, and time to progression in the phase 3 CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Merle, P.; Rimassa, L.; Ryoo, B.; Cicin, I.; Harris, W.; Banu, E.; Sarker, D.; Tan, B.; Van Vlierberghe, H.; Sen, S.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save